Congress orders federal epilepsy research overhaul—but no new money attached
S. 494 — National Plan for Epilepsy Act · Filed by Eric Schmitt (R-MO) · 27 cosponsors · Introduced Feb 10, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to review federal epilepsy research, prevention, and treatment programs, identify gaps and coordination problems, and report back to Congress within two years with recommendations for improvement. The bill requires the Secretary to consult with federal agencies, patient advocates, and medical experts to develop a coordinated national plan for epilepsy.
Why we flagged it
The bill's operative mechanism is a directed review and reporting requirement aimed at improving federal coordination of epilepsy research and care. It is a straightforward public health planning instrument with no private carve-outs or immunity provisions.
What the text implies
- The bill's effectiveness depends entirely on HHS follow-through and congressional action on recommendations—the bill itself creates no new funding, programs, or enforcement mechanisms.
- The 2-year reporting deadline may create pressure to consolidate or restructure existing epilepsy programs, potentially affecting current grant recipients and research continuity.
The full analysis lists 3 implications of this text.
Who it affects
The bill creates a structured review and coordination mechanism for epilepsy research and care without restricting any citizen rights or creating new barriers. It aims to improve health outcomes for the estimated 3.4 million Americans with epilepsy by identifying research gaps and improving care coordination.